Vertex Pharmaceuticals Inc / Ma

BANK OF AMERICA CORP /DE/ VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

2,937,030

Value ($000)

1,331,532

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,331,532	0.1%	2,937,030	12/31/2025
2025 Q3	2/3/2026	1,112,424	0.1%	2,840,424	9/30/2025
2025 Q2	8/14/2025	1,249,951	0.1%	2,807,617	6/30/2025
2025 Q1	5/15/2025	1,389,008	0.1%	2,864,998	3/31/2025
2024 Q4	2/14/2025	974,273	0.1%	2,419,353	12/31/2024
2024 Q3	11/14/2024	1,213,374	0.1%	2,608,957	9/30/2024
2024 Q2	8/14/2024	1,205,775	0.1%	2,572,485	6/30/2024
2024 Q1	5/15/2024	1,063,684	0.1%	2,544,638	3/31/2024
2023 Q4	2/14/2024	991,151	0.1%	2,435,920	12/31/2023
2023 Q3	11/14/2023	818,233	0.1%	2,353,001	9/30/2023
2023 Q2	8/14/2023	823,496	0.1%	2,340,075	6/30/2023
2023 Q1	5/12/2023	814,501	0.1%	2,585,144	3/31/2023
2022 Q4	2/10/2023	721,101	0.1%	2,497,060	12/31/2022
2022 Q3	11/14/2022	731,800	0.1%	2,527,455	9/30/2022
2022 Q2	8/12/2022	759,932	0.1%	2,696,798	6/30/2022
2022 Q1	5/16/2022	813,846	0.1%	3,118,547	3/31/2022
2021 Q4	2/8/2022	680,325	0.1%	3,098,017	12/31/2021
2021 Q3	11/15/2021	549,677	0.1%	3,030,356	9/30/2021
2021 Q2	9/13/2021	309,167	0.0%	1,533,344	6/30/2021
2021 Q1	5/14/2021	314,870	0.0%	1,465,261	3/31/2021
2020 Q4	2/10/2021	319,329	0.0%	1,351,144	12/31/2020
2020 Q3	11/13/2020	400,862	0.1%	1,473,110	9/30/2020
2020 Q2	8/14/2020	414,887	0.1%	1,429,122	6/30/2020
2020 Q1	5/15/2020	321,791	0.1%	1,352,347	3/31/2020
2019 Q4	2/14/2020	257,761	0.0%	1,177,260	12/31/2019
2014 Q1	5/15/2014	34,530	0.0%	488,253	3/31/2014
2013 Q4	2/18/2014	34,576	0.0%	465,351	12/31/2013